Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Sodium alginate prevents progression of non-alcoholic steatohepatitis and liver carcinogenesis in obese and diabetic mice
Tsuneyuki Miyazaki, Yohei Shirakami, Masaya Kubota, et al.
Oncotarget (2016) Vol. 7, Iss. 9, pp. 10448-10458
Open Access | Times Cited: 26

Showing 1-25 of 26 citing articles:

A Review of the Alleged Health Hazards of Monosodium Glutamate
Anca Zanfirescu, Anca Ungurianu, Aristides Tsatsakis, et al.
Comprehensive Reviews in Food Science and Food Safety (2019) Vol. 18, Iss. 4, pp. 1111-1134
Open Access | Times Cited: 194
Obesity: Pathophysiology, monosodium glutamate-induced model and anti-obesity medicinal plants
René Hernández-Bautista, Ayman M. Mahmoud, Mina Königsberg, et al.
Biomedicine & Pharmacotherapy (2018) Vol. 111, pp. 503-516
Open Access | Times Cited: 124
Food additives: distribution and co-occurrence in 126,000 food products of the French market
Eloi Chazelas, Mélanie Deschasaux, Bernard Srour, et al.
Scientific Reports (2020) Vol. 10, Iss. 1
Open Access | Times Cited: 123
Worldwide flavor enhancer monosodium glutamate combined with high lipid diet provokes metabolic alterations and systemic anomalies: An overview
Arnab Banerjee, Sandip Mukherjee, Bithin Kumar Maji
Toxicology Reports (2021) Vol. 8, pp. 938-961
Open Access | Times Cited: 79
Sodium Alginate Prevents Non-Alcoholic Fatty Liver Disease by Modulating the Gut–Liver Axis in High-Fat Diet-Fed Rats
Hui Zhao, Xiang Gao, Zhizuo Liu, et al.
Nutrients (2022) Vol. 14, Iss. 22, pp. 4846-4846
Open Access | Times Cited: 34
Preventive effects of the sodium glucose cotransporter 2 inhibitor tofogliflozin on diethylnitrosamine-induced liver tumorigenesis in obese and diabetic mice
Koki Obara, Yohei Shirakami, Akinori Maruta, et al.
Oncotarget (2017) Vol. 8, Iss. 35, pp. 58353-58363
Open Access | Times Cited: 57
Bioactive Compounds from Brown Algae Alleviate Nonalcoholic Fatty Liver Disease: An Extensive Review
Yu Wu, Xiaosheng Jin, Ya Zhang, et al.
Journal of Agricultural and Food Chemistry (2023) Vol. 71, Iss. 4, pp. 1771-1787
Closed Access | Times Cited: 14
Risperidone Exacerbates Glucose Intolerance, Nonalcoholic Fatty Liver Disease, and Renal Impairment in Obese Mice
Hsiao-Pei Tsai, Po‐Hsun Hou, Frank-Chiahung Mao, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 1, pp. 409-409
Open Access | Times Cited: 27
Alginate Alleviates Dextran Sulfate Sodium-Induced Colitis by Promoting Bifidobacterium animalis and Intestinal Hyodeoxycholic Acid Synthesis in Mice
Yu Pi, Xiangyu Zhang, Yujun Wu, et al.
Microbiology Spectrum (2022) Vol. 10, Iss. 6
Open Access | Times Cited: 22
Sodium alginate alleviated isoniazid-induced liver injury by modulating fecal metabolites and gut microbiota
Xinfang Wang, Jingkai Zhang, Xia Xin, et al.
International Journal of Biological Macromolecules (2025), pp. 141149-141149
Closed Access
Sodium alginate improves lipid disruption and alters the composition of the gut microbiota in farnesoid X receptor-null mice
Masaaki Miyata, K. Maeno, Rei Takagi, et al.
International Journal of Food Sciences and Nutrition (2025), pp. 1-11
Closed Access
Biological activities and health benefits of sodium alginate: A review
Xinru Li, Yi Qiao, Hui Liu
Journal of Functional Foods (2025) Vol. 129, pp. 106856-106856
Closed Access
<p>Dual SGLT1/SGLT2 Inhibitor Phlorizin Ameliorates Non-Alcoholic Fatty Liver Disease and Hepatic Glucose Production in Type 2 Diabetic Mice</p>
Aline David-Silva, João Victor Del Conti Esteves, Mychel Morais, et al.
Diabetes Metabolic Syndrome and Obesity (2020) Vol. Volume 13, pp. 739-751
Open Access | Times Cited: 30
Tropical foods as functional foods for metabolic syndrome
Oliver D. John, Ryan du Preez, Sunil K. Panchal, et al.
Food & Function (2020) Vol. 11, Iss. 8, pp. 6946-6960
Closed Access | Times Cited: 24
Inflammation-Related Carcinogenesis: Lessons from Animal Models to Clinical Aspects
Futoshi Okada, Runa Izutsu, Keisuke Goto, et al.
Cancers (2021) Vol. 13, Iss. 4, pp. 921-921
Open Access | Times Cited: 22
Algal polysaccharides and derivatives as potential therapeutics for obesity and related metabolic diseases
Zizhen Yang, Haoyu Wang, Nian Liu, et al.
Food & Function (2022) Vol. 13, Iss. 22, pp. 11387-11409
Closed Access | Times Cited: 14
Brown-Algae Polysaccharides as Active Constituents against Nonalcoholic Fatty Liver Disease
Zeinab El Rashed, Elena Grasselli, Hala Khalifeh, et al.
Planta Medica (2020) Vol. 88, Iss. 01, pp. 9-19
Closed Access | Times Cited: 21
Clozapine Worsens Glucose Intolerance, Nonalcoholic Fatty Liver Disease, Kidney Damage, and Retinal Injury and Increases Renal Reactive Oxygen Species Production and Chromium Loss in Obese Mice
Geng‐Ruei Chang, Hsien-Yueh Liu, Wei‐Cheng Yang, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 13, pp. 6680-6680
Open Access | Times Cited: 19
Suppressive effects of the sodium‑glucose cotransporter 2 inhibitor tofogliflozin on colorectal tumorigenesis in diabetic and obese mice
Junichi Kato, Yohei Shirakami, Masaya Ohnishi, et al.
Oncology Reports (2019)
Open Access | Times Cited: 18
Alpha-Glucosidase Inhibitor Voglibose Suppresses Azoxymethane-Induced Colonic Preneoplastic Lesions in Diabetic and Obese Mice
Junichi Kato, Yohei Shirakami, Taku Mizutani, et al.
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 6, pp. 2226-2226
Open Access | Times Cited: 13
Preventive Effects of Pentoxifylline on the Development of Colonic Premalignant Lesions in Obese and Diabetic Mice
Kazufumi Fukuta, Yohei Shirakami, Akinori Maruta, et al.
International Journal of Molecular Sciences (2017) Vol. 18, Iss. 2, pp. 413-413
Open Access | Times Cited: 12
Prevention of acetaminophen-induced liver injury by alginate
Eyal Shteyer, Ami Ben Ya’acov, Lidia Zolotaryova, et al.
Toxicology and Applied Pharmacology (2018) Vol. 363, pp. 72-78
Closed Access | Times Cited: 10
Pathogenetic Targets of Sea Algae Polysaccharides in Non-Alcoholic Fatty Liver Disease
Sergey P. Kryzhanovsky, L. G. Gusevа, E. Yu. Dobryakov, et al.
Antibiot Khimioter = Antibiotics and Chemotherapy (2024) Vol. 69, Iss. 7-8, pp. 67-79
Open Access
Antioxidant capacity of seaweeds: In vitro and in vivo assessment
Helena Sánchez-Ayora, Jara Pérez‐Jiménez
Elsevier eBooks (2023), pp. 299-341
Closed Access | Times Cited: 1
Alginates in Metabolic Syndrome
Senthil Arun Kumar, Lindsay Brown
Springer series in biomaterials science and engineering (2017), pp. 223-235
Closed Access | Times Cited: 2
Page 1 - Next Page

Scroll to top